Furthermore, miR-485-5p was shown to suppress esophageal squamous cell carcinoma (ESCC) progression by inhibiting flotillin-1 expression leading to reduced EMT process [43], and target PGC-1α to inhibit breast cancer cell metastasis [44]. Here, PPARGC1A is linked to breast carcinoma.